308
Views
6
CrossRef citations to date
0
Altmetric
Middle ear

Efficacy of balloon Eustachian tuboplasty on the quality of life in children with Eustachian tube dysfunction

ORCID Icon &
Pages 297-301 | Received 25 Nov 2019, Accepted 03 Jan 2020, Published online: 21 Jan 2020
 

Abstract

Background: Balloon Eustachian Tuboplasty (BET) is used as a second-line treatment in cases in which adenoidectomy, paracentesis, and VT have failed. However, studies have not investigated the efficacy of this procedure as a first-line treatment.

Objectives: To evaluate the quality of life in children with chronic Eustachian tube dysfunction (ETD) after BET using the Otitis Media-6 (OM-6) questionnaire.

Methods: We retrospectively evaluated the data of 62 children with chronic dysfunction ETD and divided patients into the following groups: 30 cases underwent BET (group 1), and 32 cases underwent ventilation tube (VT) insertion from July 2016 to April 2018. The children’s parents were instructed to complete the OM-6 questionnaire preoperatively and at 6 weeks and 1 year postoperatively.

Results:. The average preoperative scores were higher than the postoperative scores, and the average 6-week postoperative scores were higher than the average 1-year postoperative scores for both groups 1 and 2. Further, the average 6-week postoperative scores from patients in group 2 were significantly higher than those in group 1.

Conclusion and significance: Our results demonstrate that BET may be a safe, first-line intervention that positively effects the quality of life in children with chronic ETD.

Chinese abstract

背景:气囊式咽鼓管成形术(BET)是在腺样体切除术、穿刺术和VT都失败的情况下采用的二线疗法。然而, 还没有任何研究对该疗法作为一线治疗的效果进行调查。

目的:采用中耳炎-6(OM-6)问卷, 评价患慢性咽鼓管功能不全(ETD)的儿童在接受BET疗法后的生活质量。

方法:回顾性分析62例ETD患儿的临床资料, 将其分组如下:2016年7月至2018年4月, 30例接受BET治疗(组1), 32例接受通气管置入术(VT)。要求患儿家长在术前以及术后6周和1年时, 填写OM-6问卷。

结果:两组术前平均分值均高于术后平均分值, 术后6周平均分值均高于术后1年平均分值。此外, 第2组患者术后6周的平均分值明显高于第1组。

结论与意义:我们的研究结果表明, BET可能是一种安全的一线干预措施, 对慢性ETD儿童的生活质量有正面作用。

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.